Search company, investor...

Predict your next investment

EW Healthcare Partners company logo
Growth Equity
ewhealthcare.com

Investments

234

Portfolio Exits

73

Funds

15

Partners & Customers

3

About EW Healthcare Partners

EW Healthcare Partners is a venture capital firm pursuing investments in pharmaceuticals, biotechnology, medical devices, health care services and health information technology. EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been involved in the founding, investing, and/or management of healthcare companies ranging across all sectors, stages and geography.

Headquarters Location

75 Rockefeller Plaza Suite 1700A

New York, New York, 10019,

United States

646-429-1251

Want to inform investors similar to EW Healthcare Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest EW Healthcare Partners News

VitalConnect: Remote And In-Hospital Wearable Biosensor Technology Secures Over $30 Million

Aug 3, 2023

VitalConnect – a leader in remote and in-hospital wearable biosensor technology – recently announced the closing on an oversubscribed Series F financing in excess of $30 million. The funding round was led by Revelation Partners, with significant participation from the company’s existing investors, including Pacific General Ventures and EW Healthcare Partners. The additional funding round will support VitalConnect’s rapidly growing remote cardiac monitoring business while advancing key partnerships with the largest hospital systems in the United States to provide remote patient monitoring in an in-patient setting. Launched in 2011, VitalConnect has deployed hundreds of thousands of biosensors throughout the world, including leading healthcare facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. And the VitalPatch enables real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients. KEY QUOTES: “VitalConnect’s services have been widely adopted at an accelerated pace over the past 24 months, enabling our revenue to triple from 2021 to 2022, and putting us on track to nearly double revenue again in 2023. We are also experiencing significant EBITDA improvement and we expect to achieve profitability in 2024. This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.” — Peter Van Haur, CEO of VitalConnect “Revelation Partners is excited to join the distinguished list of VitalConnect investors to help further accelerate the company’s already impressive growth. VitalConnect is in the unique position of being able to meaningfully participate in multiple billion-dollar markets that are growing at double-digit rates. The adoption of the technology in the marketplace, thus far, has been unprecedented, thereby giving us confidence in the leadership team’s ability to execute. We are committed to supporting the organization to enable them to maximize both revenue and profitability.” — Fred Lee, Partner at Revelation Partners Trending on Pulse 2.0

EW Healthcare Partners Investments

234 Investments

EW Healthcare Partners has made 234 investments. Their latest investment was in VitalConnect as part of their Series F on July 7, 2023.

CBI Logo

EW Healthcare Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/18/2023

Series F

VitalConnect

$30M

No

7

1/7/2022

Series E

VitalConnect

$39M

Yes

EW Healthcare Partners, MVM Partners, and Undisclosed Investors

10

11/18/2020

Series D

COTA

$34M

Yes

6

9/11/2020

Series F

Subscribe to see more

$99M

Subscribe to see more

10

7/14/2020

Series H

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/18/2023

1/7/2022

11/18/2020

9/11/2020

7/14/2020

Round

Series F

Series E

Series D

Series F

Series H

Company

VitalConnect

VitalConnect

COTA

Subscribe to see more

Subscribe to see more

Amount

$30M

$39M

$34M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

EW Healthcare Partners, MVM Partners, and Undisclosed Investors

Sources

7

10

6

10

10

EW Healthcare Partners Portfolio Exits

73 Portfolio Exits

EW Healthcare Partners has 73 portfolio exits. Their latest portfolio exit was Abiomed on December 22, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/22/2022

Acq - P2P

$99M

5

12/21/2021

Acquired

$99M

1

10/29/2021

IPO

$99M

Public

4

10/14/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/17/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/22/2022

12/21/2021

10/29/2021

10/14/2021

2/17/2021

Exit

Acq - P2P

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

5

1

4

10

10

EW Healthcare Partners Acquisitions

12 Acquisitions

EW Healthcare Partners acquired 12 companies. Their latest acquisition was Enercon Technologies on May 18, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/18/2023

$99M

Acq - Fin

1

10/18/2022

$99M

Acquired

1

5/5/2022

Grant

$99M

$2.37M

Acq - Fin

2

4/30/2021

Subscribe to see more

$99M

Subscribe to see more

10

5/10/2012

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

5/18/2023

10/18/2022

5/5/2022

4/30/2021

5/10/2012

Investment Stage

Grant

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$2.37M

$99M

Note

Acq - Fin

Acquired

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

0

EW Healthcare Partners Fund History

15 Fund Histories

EW Healthcare Partners has 15 funds, including EW Healthcare Partners Fund 2a.

Closing Date

Fund

Fund Type

Status

Amount

Sources

8/22/2019

EW Healthcare Partners Fund 2a

Multi-Stage Venture Capital

Closed

$746.33M

4

6/11/2019

Titan Co-Investment Fund 2

$27M

1

10/28/2016

Essex Woodlands Fund IX

Industry Focused

Closed

$543.1M

3

3/30/2009

Essex Woodlands Health Ventures VIII LP (consolidated)

Subscribe to see more

Subscribe to see more

$99M

10

5/18/2006

Essex Woodlands Health Ventures VII LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

8/22/2019

6/11/2019

10/28/2016

3/30/2009

5/18/2006

Fund

EW Healthcare Partners Fund 2a

Titan Co-Investment Fund 2

Essex Woodlands Fund IX

Essex Woodlands Health Ventures VIII LP (consolidated)

Essex Woodlands Health Ventures VII LP

Fund Type

Multi-Stage Venture Capital

Industry Focused

Subscribe to see more

Subscribe to see more

Status

Closed

Closed

Subscribe to see more

Subscribe to see more

Amount

$746.33M

$27M

$543.1M

$99M

$99M

Sources

4

1

3

10

10

EW Healthcare Partners Partners & Customers

3 Partners and customers

EW Healthcare Partners has 3 strategic partners and customers. EW Healthcare Partners recently partnered with Smith & Nephew on January 1, 2012.

Date

Type

Business Partner

Country

News Snippet

Sources

1/4/2012

Partner

United Kingdom

EW Healthcare Partners News - Essex Woodlands Announces Strategic Partnership with Smith & Nephew to Fund Spinout of Biologics and Clinical Therapies Division, Creating Leading Orthopedic Biologics Company

Pantheon Ventures , a Limited Partner of Essex Woodlands , and Spindletop Healthcare Capital may participate alongside Essex Woodlands in the investment .

5

1/4/2012

Partner

United Kingdom

Subscribe to see more

Subscribe to see more

10

1/4/2012

Partner

United Kingdom

Subscribe to see more

Subscribe to see more

10

Date

1/4/2012

1/4/2012

1/4/2012

Type

Partner

Partner

Partner

Business Partner

Country

United Kingdom

United Kingdom

United Kingdom

News Snippet

EW Healthcare Partners News - Essex Woodlands Announces Strategic Partnership with Smith & Nephew to Fund Spinout of Biologics and Clinical Therapies Division, Creating Leading Orthopedic Biologics Company

Pantheon Ventures , a Limited Partner of Essex Woodlands , and Spindletop Healthcare Capital may participate alongside Essex Woodlands in the investment .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

EW Healthcare Partners Team

21 Team Members

EW Healthcare Partners has 21 team members, including , .

Name

Work History

Title

Status

Marty Sutter

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Marty Sutter

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.